Sio Gene Therapies Stock Price, News & Analysis
Company Description
Sio Gene Therapies (OTC: SIOX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
SIOX stock has declined 100.0% over the past year.
This page provides a comprehensive overview of SIOX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sio Gene Therapies (SIOX) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Sio Gene Therapies has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all SIOX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SIOX Company Profile & Sector Positioning
Sio Gene Therapies (SIOX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.